Potential late effects of SARS-CoV-2 (COVID-19) infection: parallels to cancer late effects Richard P. PhippsPatricia J. SimeConnor R. Phipps EDITORIAL 04 February 2021 Pages: 1 - 2
Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward? Gábor TigyiMélanie A. DacheuxSue Chin Lee COMMENTARY 17 January 2021 Pages: 3 - 5
Current methods in translational cancer research Michael W. LeeMihailo MiljanicAnna Capasso Non-Thematic Review Open access 14 September 2020 Pages: 7 - 30
Interaction between adipose tissue and cancer cells: role for cancer progression Jean-François DumasLucie Brisson Non-Thematic Review 02 October 2020 Pages: 31 - 46
Beyond tradition and convention: benefits of non-traditional model organisms in cancer research Rebecca M. HarmanSanjna P. DasGerlinde R. Van de Walle Non-Thematics Review 28 October 2020 Pages: 47 - 69
Visualizing cancer extravasation: from mechanistic studies to drug development Xiao ChengKe Cheng Non-Thematic Review 06 November 2020 Pages: 71 - 88
Targeting the cytoskeleton against metastatic dissemination Carmen RuggieroEnzo Lalli Non-Thematic Review 20 January 2021 Pages: 89 - 140
Epigenetic modulation of immunotherapy and implications in head and neck cancer Liye ZhouNa XuRavindra Uppaluri Non-Thematic Review Open access 05 January 2021 Pages: 141 - 152
Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology? Christin RiessNina IrmscherClaudia Maletzki Non-Thematic Review Open access 08 November 2020 Pages: 153 - 171
Neuroblastoma and the epigenome Irfete S. FetahuSabine Taschner-Mandl Non-Thematic Review Open access 06 January 2021 Pages: 173 - 189
Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis Karlijn van LoonElisabeth J. M. HuijbersArjan W. Griffioen Non-Thematic Review Open access 02 November 2020 Pages: 191 - 203
Cohesive cancer invasion of the biophysical barrier of smooth muscle William L. HarrymanKendra D. MarrAnne E. Cress Non-Thematic Review 04 January 2021 Pages: 205 - 219
Neutrophil-derived granule cargoes: paving the way for tumor growth and progression Kavita RawatSaima SyedaAnju Shrivastava Non-Thematic Review 12 January 2021 Pages: 221 - 244
An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression Aamir Ali KhanXinhui LiuHua Huang Non-Thematic Review 10 January 2021 Pages: 245 - 272
Macrophages in multiple myeloma: key roles and therapeutic strategies Khatora S. OppermanKate VandykeAndrew C. W. Zannettino Non-Thematic Review 06 January 2021 Pages: 273 - 284
Potential mechanisms of tumor progression associated with postoperative infectious complications Hironori TsujimotoMinako KobayashiHideki Ueno Clinical 03 January 2021 Pages: 285 - 296
Galectin-3: an immune checkpoint target for musculoskeletal tumor patients Kosei NakajimaVitaly BalanAvraham Raz Clinical Open access 14 September 2020 Pages: 297 - 302
The role of caspase-8 in the tumor microenvironment of ovarian cancer Izabela KostovaRanadip MandalKlaus Strebhardt Clinical Open access 07 October 2020 Pages: 303 - 318
Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies Karuna MittalJaspreet KaurRitu Aneja CLINICAL 26 October 2020 Pages: 319 - 339
Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and/or immunotherapy) in brain metastases: a systematic review Pierre-Yves BoriusJean RégisIgor Latorzeff Clinical 04 January 2021 Pages: 341 - 354
Pancreatic adenocarcinoma: molecular drivers and the role of targeted therapy Bayan Al-ShareNour HammadMaria Diab Clinical 04 January 2021 Pages: 355 - 371
